Skip to main content

Undocking of an extensive ciliary network induces proteostasis and cell fate switching resulting in severe primary ciliary dyskinesia.

Science translational medicine2025-01-29PubMed
Total: 87.0Innovation: 9Impact: 8Rigor: 9Citation: 8

Summary

This mechanistic study shows that CCDC39/CCDC40 variants disrupt docking of the multiciliary network, triggering proteostasis stress and cell fate switching in multiciliated airway cells, offering an explanation for severe primary ciliary dyskinesia beyond motility loss. The work reframes PCD as a ciliopathy involving structural-network failure and proteostatic responses.

Key Findings

  • CCDC39/CCDC40 variants cause undocking of the multiciliary network in human multiciliated cells.
  • Proteostasis stress responses are activated, linking structural failure to cellular dysfunction.
  • Cell fate switching accompanies ciliary network disruption, explaining severe PCD beyond motility loss.

Clinical Implications

Clinicians should consider that severe PCD phenotypes may reflect proteostasis and epithelial cell fate alterations; biomarkers of proteotoxic stress and imaging of ciliary network integrity could refine diagnosis and stratification.

Why It Matters

It identifies a non-motility mechanism for severe PCD, opening new avenues for diagnostics and therapies targeting proteostasis and ciliary anchoring. The translational framing in human systems raises broad interest in airway ciliopathies.

Limitations

  • Abstract indicates cellular systems; in vivo validation and longitudinal patient data are not detailed
  • Quantitative prevalence and generalizability across PCD genotypes require further study

Future Directions

Validate proteostasis biomarkers in patient cohorts, test modulators of ciliary anchoring and proteostasis as therapeutic candidates, and map timelines of fate switching in airway epithelium in vivo.

Study Information

Study Type
Basic/Mechanistic research
Research Domain
Pathophysiology
Evidence Level
III - Well-executed mechanistic study in human cellular systems with disease variants
Study Design
OTHER